Technology

Perrigo REJECTS Mylan NV $27 Billion Offer, Urges Shareholders To Do The Same

Perrigo recently rejected Mylan NV's tender offer to acquire their outstanding shares. Perrigo, a generic and over-the-counter drug maker, has urged its shareholders to reject Mylan NV's $27 billion tender offer to buy their shares.
Real Time Analytics